Annual Operating Profit
-$35.24 M
+$4.53 M+11.40%
December 31, 2023
Summary
- As of February 10, 2025, CALT annual operating income is -$35.24 million, with the most recent change of +$4.53 million (+11.40%) on December 31, 2023.
- During the last 3 years, CALT annual operating profit has risen by +$6.51 million (+15.60%).
Performance
CALT Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Profit
-$2.95 M
+$16.70 M+84.97%
June 30, 2024
Summary
- As of February 10, 2025, CALT quarterly operating income is -$2.95 million, with the most recent change of +$16.70 million (+84.97%) on June 30, 2024.
- Over the past year, CALT quarterly operating profit has increased by +$16.70 million (+84.97%).
Performance
CALT Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Operating Profit
-$36.89 M
+$4.20 M+10.22%
June 30, 2024
Summary
- As of February 10, 2025, CALT TTM operating income is -$36.89 million, with the most recent change of +$4.20 million (+10.22%) on June 30, 2024.
- Over the past year, CALT TTM operating profit has increased by +$4.20 million (+10.22%).
Performance
CALT TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
CALT Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +11.4% | +85.0% | +10.2% |
3 y3 years | +15.6% | +86.8% | +43.1% |
5 y5 years | -134.5% | -132.7% | -1138.3% |
CALT Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +71.9% | -156.8% | +728.3% | +62.6% | +94.4% |
5 y | 5-year | +1093.9% | +71.9% | -156.8% | +728.3% | +1138.3% | +94.4% |
alltime | all time | +1093.9% | +71.9% | -132.7% | +728.3% | +2890.4% | +94.4% |
Calliditas Therapeutics AB (Publ) Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2024 | - | -$2.95 M(-85.0%) | -$36.89 M(-10.2%) |
Mar 2024 | - | -$19.65 M(-3963.2%) | -$41.09 M(+6.1%) |
Dec 2023 | -$35.24 M(-11.4%) | $508.70 K(-103.4%) | -$38.72 M(+13.8%) |
Sep 2023 | - | -$14.79 M(+106.8%) | -$34.02 M(+50.0%) |
Jun 2023 | - | -$7.15 M(-58.6%) | -$22.68 M(-38.7%) |
Mar 2023 | - | -$17.28 M(-432.1%) | -$36.98 M(-12.1%) |
Dec 2022 | -$39.77 M(-34.3%) | $5.20 M(-250.6%) | -$42.07 M(-41.4%) |
Sep 2022 | - | -$3.46 M(-83.9%) | -$71.73 M(+6.5%) |
Jun 2022 | - | -$21.45 M(-4.1%) | -$67.37 M(+3.8%) |
Mar 2022 | - | -$22.37 M(-8.6%) | -$64.88 M(+7.2%) |
Dec 2021 | -$60.56 M(+45.1%) | -$24.46 M(-2789.0%) | -$60.52 M(+16.0%) |
Sep 2021 | - | $909.70 K(-104.8%) | -$52.16 M(-19.7%) |
Jun 2021 | - | -$18.96 M(+5.3%) | -$64.92 M(+22.9%) |
Mar 2021 | - | -$18.01 M(+11.8%) | -$52.84 M(+24.8%) |
Dec 2020 | -$41.75 M | -$16.10 M(+35.9%) | -$42.36 M(+50.6%) |
Sep 2020 | - | -$11.85 M(+72.1%) | -$28.12 M(+29.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2020 | - | -$6.89 M(-8.5%) | -$21.76 M(+272.8%) |
Mar 2020 | - | -$7.52 M(+303.3%) | -$5.84 M(+95.9%) |
Dec 2019 | -$2.95 M(-80.4%) | -$1.86 M(-66.0%) | -$2.98 M(-48.9%) |
Sep 2019 | - | -$5.49 M(-160.7%) | -$5.83 M(+52.0%) |
Jun 2019 | - | $9.04 M(-293.9%) | -$3.83 M(-74.4%) |
Mar 2019 | - | -$4.66 M(-1.1%) | -$14.98 M(-0.4%) |
Dec 2018 | -$15.02 M(+51.2%) | -$4.71 M(+34.8%) | -$15.04 M(-1.1%) |
Sep 2018 | - | -$3.50 M(+66.2%) | -$15.21 M(+9.7%) |
Jun 2018 | - | -$2.10 M(-55.4%) | -$13.86 M(+2.5%) |
Mar 2018 | - | -$4.72 M(-3.4%) | -$13.52 M(+34.8%) |
Dec 2017 | -$9.93 M(+50.2%) | -$4.89 M(+127.4%) | -$10.03 M(+95.1%) |
Sep 2017 | - | -$2.15 M(+22.2%) | -$5.14 M(+71.9%) |
Jun 2017 | - | -$1.76 M(+42.6%) | -$2.99 M(+142.6%) |
Mar 2017 | - | -$1.23 M | -$1.23 M |
Dec 2016 | -$6.61 M(+8.5%) | - | - |
Dec 2015 | -$6.10 M | - | - |
FAQ
- What is Calliditas Therapeutics AB (publ) annual operating income?
- What is the all time high annual operating profit for Calliditas Therapeutics AB (publ)?
- What is Calliditas Therapeutics AB (publ) annual operating profit year-on-year change?
- What is Calliditas Therapeutics AB (publ) quarterly operating income?
- What is the all time high quarterly operating profit for Calliditas Therapeutics AB (publ)?
- What is Calliditas Therapeutics AB (publ) quarterly operating profit year-on-year change?
- What is Calliditas Therapeutics AB (publ) TTM operating income?
- What is the all time high TTM operating profit for Calliditas Therapeutics AB (publ)?
- What is Calliditas Therapeutics AB (publ) TTM operating profit year-on-year change?
What is Calliditas Therapeutics AB (publ) annual operating income?
The current annual operating profit of CALT is -$35.24 M
What is the all time high annual operating profit for Calliditas Therapeutics AB (publ)?
Calliditas Therapeutics AB (publ) all-time high annual operating income is -$2.95 M
What is Calliditas Therapeutics AB (publ) annual operating profit year-on-year change?
Over the past year, CALT annual operating income has changed by +$4.53 M (+11.40%)
What is Calliditas Therapeutics AB (publ) quarterly operating income?
The current quarterly operating profit of CALT is -$2.95 M
What is the all time high quarterly operating profit for Calliditas Therapeutics AB (publ)?
Calliditas Therapeutics AB (publ) all-time high quarterly operating income is $9.04 M
What is Calliditas Therapeutics AB (publ) quarterly operating profit year-on-year change?
Over the past year, CALT quarterly operating income has changed by +$16.70 M (+84.97%)
What is Calliditas Therapeutics AB (publ) TTM operating income?
The current TTM operating profit of CALT is -$36.89 M
What is the all time high TTM operating profit for Calliditas Therapeutics AB (publ)?
Calliditas Therapeutics AB (publ) all-time high TTM operating income is -$1.23 M
What is Calliditas Therapeutics AB (publ) TTM operating profit year-on-year change?
Over the past year, CALT TTM operating income has changed by +$4.20 M (+10.22%)